Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virt
Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations
Ophthalmology Times' Sheryl Stevenson sits down with Kristen Brotherson, vice president of U.S.
Ophthalmology Times' Sheryl Stevenson speaks with Robert Dempsey, TearClear's new CEO, on his goals for the company, its mission and vision in the future of the coronavirus, as well as what to keep an eye out for at the 2020 ASC
Danny Haddad, MD, chief of program at Orbis International, shares an update on how the company's operations have shifted during the coronavirus pandemic, as well as the record-breaking impact on one
Gary Lelli, MD, vice chair of ophthalmology and director of ocular plastic surgery at the Weill Cornell Medical Center in New York, discusses how the facility has adapted its patient services during the coronavirus pandemic.
Daria Lemann-Blumenthal, CEO of BELKIN Laser Ltd, provides an update on how the company's operations have continued to progress amid the coronavirus pandemic.
Ellie Chabi, MD, therapeutic area head for Glaucoma & Neuroprotection, lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insight on the company's role in the panel discussion focusing on new
Victor Chan, MBA, MS, director of U.S.